| Nov 7 |
Iovance Biotherapeutics: Q3 Earnings Snapshot
|
| Nov 7 |
Iovance Biotherapeutics GAAP EPS of -$0.28 beats by $0.02, revenue of $58.6M beats by $4.78M
|
| Nov 7 |
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024
|
| Nov 6 |
Iovance Biotherapeutics Q3 2024 Earnings Preview
|
| Nov 5 |
High Growth Tech Stocks to Watch in November 2024
|
| Oct 31 |
Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024
|
| Oct 24 |
Why Iovance Biotherapeutics Stock Triumphed on Thursday
|
| Oct 24 |
UBS launches SMID cap biotechs with cancer, autoimmunity in focus
|
| Oct 18 |
State Street Corp's Strategic Acquisition in Iovance Biotherapeutics Inc
|
| Oct 16 |
Is Iovance Biotherapeutics Inc. (IOVA) the Most Promising Stock to Buy According to Wall Street Analysts?
|
